Sep 27, 2002 | NEWS
Alliance brings together world-leading capabilities in genetics and drug development to speed the discovery of new treatments Reykjavik, ICELAND, September 27, 2002 — deCODE genetics (Nasdaq/Nasdaq Europe:DCGN) and Merck & Co., Inc. (NYSE:MRK) today announced the...
Jul 24, 2002 | NEWS
Research yields promising drug targets impacting underlying biology of the disease; Findings form the basis of deCODE’s most advanced drug discovery program Reykjavik, ICELAND, July 24, 2002 — deCODE genetics (Nasdaq/Nasdaq Europe:DCGN) today announced the publication...
Jul 17, 2002 | NEWS
Discoveries will be used to develop novel diagnostic tools and therapies for asthma and allergies, and to optimize patient benefit from existing drugs Reykjavik, ICELAND, July 17, 2002 — deCODE genetics (Nasdaq/Nasdaq Europe:DCGN) today announced that its scientists...
Jun 26, 2002 | NEWS
deCODE study published this month reveals the strongest genetic linkage ever found to the common form of the condition. Reykjavik, ICELAND, June 26, 2002 — deCODE genetics (Nasdaq/Nasdaq Europe:DCGN) today announced that a team of its scientists has located a gene...
Jun 9, 2002 | NEWS
· Landmark study creates “user’s guide” to the human genome; will aid in finalizing the assembly of the genome and in applying genomics to create better medicine. · Leverages deCODE’s genealogical resources, genotyping capabilities and software; results...
Feb 28, 2002 | NEWS
February 28, 2002 A woman has more than five times the normal risk of developing endometriosis if her sister has the disease, according to research published today (Thursday 28 February) in Europe’s leading reproductive medicine journal, Human Reproduction*. Moreover,...
